|
PPIL5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.057800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.333810E-01 |
| Normal-vs-Stage2 |
7.334800E-01 |
| Normal-vs-Stage3 |
1.204610E-01 |
| Normal-vs-Stage4 |
1.772430E-01 |
| Stage1-vs-Stage2 |
2.283800E-01 |
| Stage1-vs-Stage3 |
8.861800E-01 |
| Stage1-vs-Stage4 |
7.521600E-01 |
| Stage2-vs-Stage3 |
2.574200E-01 |
| Stage2-vs-Stage4 |
2.986600E-01 |
| Stage3-vs-Stage4 |
8.580200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.048820E-01 |
| Normal-vs-AfricanAmerican |
5.367400E-01 |
| Normal-vs-Asian |
2.216800E-01 |
| Caucasian-vs-AfricanAmerican |
7.258000E-01 |
| Caucasian-vs-Asian |
8.499200E-01 |
| AfricanAmerican-vs-Asian |
7.015200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.509760E-01 |
| Normal-vs-Female |
9.866200E-02 |
| Male-vs-Female |
9.785600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.610990E-01 |
| Normal-vs-Age(41-60Yrs) |
3.178000E-02 |
| Normal-vs-Age(61-80Yrs) |
7.311800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.725200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.353970E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.293200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.129600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.019700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.452600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.882400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.378200E-01 |
| Classical-VS-Follicular |
4.089600E-01 |
| Classical-VS-Other |
2.277000E-01 |
| Classical-VS-Normal |
1.362190E-01 |
| Tall-VS-Follicular |
9.566200E-01 |
| Tall-VS-Other |
1.660780E-01 |
| Tall-VS-Normal |
5.469400E-01 |
| Follicular-VS-Other |
2.051400E-01 |
| Follicular-VS-Normal |
4.177200E-01 |
| Other-VS-Normal |
1.290440E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.006400E-01 |
| Normal-vs-N1 |
4.923400E-03 |
| N0-vs-N1 |
2.060100E-02 |
|
|
